Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net sales:
Net sales	$ 3,063	$ 3,071	$ 9,596	$ 8,625
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	612	648	2,014	1,896
Other Depreciation and Amortization	293	297	897	861
Restructuring and other charges, net	4	(6)	(5)	(34)
Gains on sales of fixed assets	0	1	2	1
Goodwill, Impairment Loss	(2,250)	0	(2,250)	0
Impairment of long-lived assets	0	0	(120)	0
Shareholder Activism Related Costs	0	0	(3)	(7)
Business Divestiture Costs	(31)	(16)	(91)	(21)
Severance Costs	0	(22)	(4)	(28)
Global Shared Services Implementation Costs	(1)	0	(1)	0
Transaction related costs	(1)	0	(2)	0
Interest expense	(83)	(74)	(232)	(216)
Other income, net	33	26	43	44
Income before taxes	(2,035)	250	(1,620)	240
Corporate and Other
Segment Adjusted Operating EBITDA:
Integration-related costs	(25)	(24)	(73)	(80)
Restructuring and other charges, net	4	(6)	(5)	(34)
Health & Biosciences
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	(1)	(1)	(2)	(5)
Goodwill, Impairment Loss	(2,250)		(2,250)
Pharma Solutions
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	0	0	0	(1)
Goodwill, Impairment Loss			0
Taste
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	0	(5)	(3)	(25)
Goodwill, Impairment Loss			0
Scent [Member]
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	5	0	0	(3)
Goodwill, Impairment Loss			0
Operating Segments | Health & Biosciences
Net sales:
Net sales	512	618	1,838	1,683
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	137	151	513	469
Operating Segments | Pharma Solutions
Net sales:
Net sales	257	211	750	605
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	69	40	192	131
Operating Segments | Taste
Net sales:
Net sales	1,703	1,662	5,252	4,638
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	287	327	981	921
Operating Segments | Scent [Member]
Net sales:
Net sales	591	580	1,756	1,699
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	119	130	328	375
Nutrition & Biosciences, Inc
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net			(39)
Nutrition & Biosciences, Inc | Corporate and Other
Segment Adjusted Operating EBITDA:
N&B Inventory Step-Up Costs	0	14	0	(363)
Transaction related costs	0	0	0	(91)
Frutarom | Corporate and Other
Segment Adjusted Operating EBITDA:
Transaction related costs	$ 0	$ 0	$ (1)	$ 0